More about

Polyarticular Course Juvenile Idiopathic Arthritis

News
November 14, 2022
2 min read
Save

Biologic, conventional DMARDs achieve better results in JIA when started together

PHILADELPHIA — Patients with juvenile idiopathic arthritis started on conventional synthetic and biologic disease-modifying antirheumatic drug therapy concurrently had better results than patients on other plans, according to data presented here.